Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

New Jersey's S 1865 adds seven specific illicit fentanyl analogs - Furanyl Fentanyl, 3-Methylfentanyl, 3-Methyl Butyrylfentanyl, Valeryl Fentanyl, Norfentanyl, Para-Fluorobutyryl-Fentanyl, and Carfentanyl - to Schedule I of the state's Controlled Dangerous Substances Act. This formalizes their current administrative classification (already in effect since 2017), meaning these substances are now legally treated as having high abuse potential with no accepted medical use. The bill directly affects law enforcement, healthcare providers, and individuals handling these compounds, requiring strict regulatory controls. Prescription fentanyl remains classified separately as a Schedule II substance.